Yılmaz Nurdan, Erdal Akın, Demir Osman
Department of Physical Medicine and Rehabilitation, Medicine Faculty of Gaziosmanpaşa University, Tokat, Turkey.
Department of Physical Medicine and Rehabilitation, Medicine Faculty of Atatürk University, Erzurum, Turkey.
Turk J Phys Med Rehabil. 2020 Aug 18;66(3):351-359. doi: 10.5606/tftrd.2020.3917. eCollection 2020 Sep.
This study aims to compare the effectiveness of dry needling (DN) and kinesiotaping (KT) therapies on pain, quality of life, depression, and physical function in the treatment of myofascial pain syndrome (MPS).
The study included a total of 60 patients (4 males, 56 females; mean age 31.2±9.8 years; range, 18 to 56 years) diagnosed with MPS between January 2014 and June 2014. The patients were randomly divided into two treatment groups: the DN group (n=30) and KT group (n=30). Both groups performed stretching and postural exercises. The scales used for measurements were the Visual Analog Scale (VAS) for pain, a pressure algometer for the pressure-pain threshold, the Short Form-36 (SF-36) for the quality of life, Beck Depression Inventory (BDI) for depression, and the Neck Pain and Disability Scale (NPDS) for physical function. The patients were evaluated by a single assessor three times: pre-treatment, at the end of the treatment, and two months after the treatment.
Both DN and KT provided significant improvements for all baseline measurements (VAS, pressure pain threshold, all subscales of SF-36, BDI, and NPDS scores) at the end of the treatment and two months after the treatment (p<0.05). However, there was no significant difference between the groups in all measurements (p>0.05).
Kinesiotaping is as an effective method as DN in the treatment of MPS. It can be served as a non-invasive alternative to patients with needle phobia.
本研究旨在比较干针疗法（DN）和肌内效贴扎疗法（KT）在治疗肌筋膜疼痛综合征（MPS）时对疼痛、生活质量、抑郁和身体功能的疗效。
本研究共纳入60例于2014年1月至2014年6月期间被诊断为MPS的患者（4例男性，56例女性；平均年龄31.2±9.8岁；范围18至56岁）。患者被随机分为两个治疗组：DN组（n = 30）和KT组（n = 30）。两组均进行拉伸和姿势练习。用于测量的量表包括疼痛视觉模拟量表（VAS）、压力痛阈测量用压力痛觉计、生活质量简表（SF - 36）、抑郁用贝克抑郁量表（BDI）以及身体功能用颈部疼痛和功能障碍量表（NPDS）。由一名评估者对患者进行三次评估：治疗前、治疗结束时以及治疗后两个月。
在治疗结束时和治疗后两个月，DN和KT对所有基线测量指标（VAS、压力痛阈、SF - 36所有子量表、BDI和NPDS评分）均有显著改善（p<0.05）。然而，两组在所有测量指标上均无显著差异（p>0.05）。
肌内效贴扎疗法在治疗MPS方面与干针疗法一样有效。它可作为有针刺恐惧症患者的一种非侵入性替代方法。
